Publication date: Sep 13, 2019 Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. It is typically associated with motor symptoms originating from the degeneration of nigrostriatal dopamine ... Read more

Publication date: Sep 13, 2019 Stephenson, D., Hill, D., Cedarbaum, J.M., Tome, M., Vamvakas, S., Romero, K., Conrado, D.J., Dexter, D.T., Seibyl, J., Jennings, D., Nicholas, T., Matthews, D., Xie, ... Read more

Publication date: Sep 16, 2019 Synucleinopathies share filamentous α-synuclein assemblies in nerve cells and glial cells. We ... Read more

Publication date: Sep 16, 2019 Parkinson’s disease (PD) is a common neurodegenerative disease that lacks therapies to prevent progressive neurodegeneration. Impaired energy metabolism and reduced ATP levels are common features ... Read more

Publication date: Sep 11, 2019 Ellis, T. Exercise in Parkinson’s disease: are we narrowing in on the essential elements? 22311. 2019 Lancet Neurol. Concepts Keywords Lancet Therapy Parkinson Parkinson Lancet ... Read more

Publication date: Sep 11, 2019 We aimed to investigate the effects of changes in sleep architecture on long-term clinical outcome in patients with Parkinson’s disease (PD) who underwent deep brain ... Read more

Publication date: Sep 11, 2019 High-intensity aerobic exercise might attenuate the symptoms of Parkinson’s disease, but high-quality evidence is scarce. Moreover, long-term adherence remains challenging. We aimed to evaluate the ... Read more